Medical References | Vector Surgical

“ACR-ACS-CAP-SSO Practice Guideline for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma.” American College of Radiology. Revised,2006; Extended, 2011.
Adsay, N. V., Basturk, O., Saka, B., Bagci, P., Ozdemir, D., Balci, S., … & Weaver, D. W. “Whipple Made Simple For Surgical Pathologists: Orientation, Dissection, and Sampling of Pancreaticoduodenectomy Specimens For a More Practical and Accurate Evaluation of Pancreatic, Distal Common Bile Duct, and Ampullary Tumors.” The American journal of surgical pathology 38.4 (2014): 480-493.
Ananthakrishnan, P.; Balci, F.L.; and Crowe, J.P. “Optimizing Surgical Margins in Breast Conservation.” International Journal of Surgical Oncology 2012 (2012): 585670.
“Anatomic Pathology Checklist – Predictive Markers.” College of American Pathologists’ CAP Accreditation Program. ANP. 22998. July 11, 2011.
Britton, P.D.; Sonoda, L.I.; Yamamoto, A.K.; Koo, B.; Soh, E.; and Goud, A. “Breast Surgical Specimen Radiographs: How Reliable Are They?” European Journal of Radiology 79 (2011): 245-249.
Camp, E.R.; McAuliffe, P.F.; Gilroy, J.S.; Morris, C.G.; Lind, D.S.; Mendenhall, N.P.; and Copeland, E.M. III. “Minimizing Local Recurrence After Breast Conserving Therapy Using Intraoperative Shaved Margins to Determine Pathologic Tumor Clearance.” Journal of the American College of Surgeons 201.6 (2005): 855-861.
Dement, J.M.; Epling, C.; Ostbye, T.; Pompeii, L.A.; and Hunt, D.L. “Blood and Body Fluid Exposure Risks Among Health Care Workers: Results From the Duke Health and Safety Surveillance System.” American Journal of Industrial Medicine 46 (2004): 637-648.
Dexter, F.; Macario, A.; and Lubarsky, D.A. “The Impact on Revenue of Increasing Patient Volume at Surgical Suites with Relatively High Operating Room Utilization.” Anesthesia and Analgesia 92.5 (2001): 1215-1221.
Dooley, W.C. and Parker, J. “Understanding the Mechanisms Creating False Positive Lumpectomy Margins.” American Journal of Surgery 190 (2005): 606-608.
Evans, D. B., Farnell, M. B., Lillemoe, K. D., Vollmer Jr, C., Strasberg, S. M., & Schulick, R. D. “Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.” Annals of surgical oncology 16.7 (2009): 1736-1744.
Gage, I.; Schnitt, S.J.; Nixon, A.J.; Silver, B.; Recht, A.; Troyan, S.L.; Eberlein, T.; Love, S.M.; Gelman, R.; Harris, J.R.; and Connolly, J.L. “Pathologic Margin Involvement and the Risk of Recurrence in Patients Treated with Breast-Conserving Therapy.” Cancer 78.9 (1996): 1921-1928.
Gibson, G.R.; Lesnikoski, B.A.; Yoo, J.; Mott, L.A.; Cady, B.; and Barth, R.J. Jr. “A Comparison of Ink-Directed and Traditional Whole-Cavity Re-Excision for Breast Lumpectomy Specimens with Positive Margins.” Annals of Surgical Oncology 8.9 (2001): 693-704.
Guthrie, T.H. “Breast Cancer Litigation: An Update with Practice Guidelines.” The Breast Journal 5.5 (1999): 335-339.
Jackson, R.L. “The Business of Surgery. Managing the OR as a Profit Center Requires More Than Just IT. It Requires a Profit-Making Mindset, too.” Health Management Technology 23.7 (2002): 20-22.
Jorns, J.M.; Visscher, D.; Sabel, M.; Breslin, T.; Healy, P.; Daignaut, S.; Myers, J.L.; and Wu, A.J. “Intraoperative Frozen Section Analysis of Margins in Breast Conserving Surgery Significantly Decreases Reoperative Rates: One-Year Experience at an Ambulatory Surgical Center.” American Journal of Clinical Pathology 138.5 (2012): 657-669.
Kaplan, R.S. and Porter, M.E. “How to Solve the Cost Crisis in Health Care.” Harvard Business Review 89.9 (September 2011): 47-64.
Katz, M. H., Merchant, N. B., Brower, S., Branda, M., Posner, M. C., Traverso, L. W., … & Pisters, P. W. “Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.” Annals of surgical oncology 18.2 (2011): 337-344.
Kosemehmetoglu, K.; Guner, G.; and Ates, D. “Indian Ink vs. Tissue Marking Dye: A Quantitative Comparison of Two Widely Used Macroscopical Staining Tools.” Virchows Archiv 457.1 (2010): 21-25.
Kuerer, H.M. “If At First You Don’t Succeed: Mastectomy?” Annals of Surgical Oncology 12.11 (2005): 864-865.
Landercasper, J.; Attai, D.; Atisha, D.; Beitsch, P., Bosserman, L.; Boughey, J.; Carter, J.; Edge, S.; Feldman, S.; Froman, J.; Greenberg, C.; Kaufman, C.; Morrow, M.; Pockaj, B.; Silverstein, M.; Solin, L.; Staley, A.; Vicini, F.; Wilke, L.; Yang, W.; & Cody III, H. “Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference” Annals of Surgical Oncology 22.10 (2015): 3174-3183

Lovrics, P.J.; Cornacchi, S. D.; Farrokhyar, F.; Garnett, A.; Chen, V.; Franic, S.; and Simunovic, M. “The Relationship Between Surgical Factors and Margin Status After Breast-Conservation Surgery for Early Stage Breast Cancer.” The American Journal of Surgery (2009): 197, 740-746.
MacDonald, H.R.; Silverstein, M.J.; Mabry, H.; Moorthy, B.; Ye, W.; Epstein, M.S.; Holmes, D.; Silberman, H.; and Lagios, M. “Local Control in Ductal Carcinoma In Situ Treated by Excision Alone: Incremental Benefit of Larger Margins.” American Journal of Surgery 190.4 (2005): 521-525.
McCahill, L.E.; Single, R.M.; Aiello Bowles, E.J.; Feigelson, H.S.; James, T.A.; Barney, T.; Engel, J.M.; and Onitilo, A.A. “Variability in Reexcision Following Breast Conservation Surgery.” Journal of the American Medical Association 307.5 (2012): 467-475.
McCormick, J.T.; Keleher, A.J.; Tikhomirov, V.B.; Budway, R.J.; and Caushaj, P.F. “Analysis of the Use of Specimen Mammography in Breast Conservation Therapy.”American Journal of Surgery 188.4 (2004): 433-436.
Menes, T.S.; Tartter, P.I.; Bleiweiss, I.; Godbold, J.H.; Estabrook, A.; and Smith, S.R. “The Consequence of Multiple Re-excisions to Obtain Clear Lumpectomy Margins in Breast Cancer Patients.” Annals of Surgical Oncology 12.11 (2005): 881-885.
Merkow, R. P., Bilimoria, K. Y., Bentrem, D. J., Pitt, H. A., Winchester, D. P., Posner, M. C., … & Pawlik, T. M. “National Assessment of Margin Status as a Quality Indicator after Pancreatic Cancer Surgery.” Annals of surgical oncology 21.4 (2014): 1067-1074.
Mitnick, J.S.; Vazquez, M.F.; Kronovet, S.Z.; and Roses, D.F. “Malpractice Litigation Involving Patients with Carcinoma of the Breast.” Journal of the American College of Surgeons 181.4 (1995): 315-321.
Molina, M.A.; Snell, S.; Franceschi, D.; Jorda, M.; Gomez, C.; Moffat, F.L.; Powell, J.; and Avisar, E. “Breast Specimen Orientation.” Annals of Surgical Oncology 16 (2009): 285-288.
Osuch, J.R.; Bonham, V.L.; and Morris, L.L. “Primary Care Guide to Managing a Breast Mass: A Legal Perspective on Risk Management.” Medscape Women’s Health 3.5 (1998): 3.
“Policy statement on routine orientation of excised breast specimens.” American Society of Breast Disease (www.asbd.org). June 6, 2005.
“Practice Guideline for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma.” American College of Radiology. Jan. 1, 2002.
Quebbeman, E. J.; Telford, G. L.; Hubbard, S.; Wadsworth, K.; Hardman, B.; Goodman, H.; and Gottlieb, M.S. “Risk of Blood Contamination and Injury to Operating Room Personnel.” Annals of Surgery (1991): 614-620.
Rebner, M; Pennes, D.R.; Baker, D.E.; Adler, D.D.; and Boyd, P. “Two-View Specimen Radiography in Surgical Biopsy of Nonpalpable Breast Masses.” American Journal of Roentgenology 149 (1987): 283-285.
Revesz, E. and Khan, S.A. “What Are Safe Margins of Resection for Invasive and In Situ Breast Cancer?” Oncology 25.10 (2011): 890-895.
Silverstein, M.J.; Lagios, M.D.; Groshen, S.; Waisman, J.R.; Lewinsky, B.S.; Martino, S.; Gamagami, P.; and Colburn, W.J. “The Influence of Margin Width on Local Control of Ductal Carcinoma In Situ of the Breast.” New England Journal of Medicine 340.19 (1999): 1455-1461.
Singh, M.; Singh, G.; Hogan, K.T.; Atkins, K.A.; and Schroen, A.T. “The Effect of Intraoperative Specimen Inking on Lumpectomy Re-excision Rates.” World Journal of Surgical Oncology 8.4 (2010).
Skripenova, S. and Layfield, L.J. “Initial Margin Status for Invasive Ductal Carcinoma of the Breast and Subsequent Identification of Carcinoma in Reexcision Specimens.”Archives of Pathology and Laboratory Medicine 134.1 (2010): 109-114.
Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben-Josef, E., Benson, A. B., Casper, E. S., … & Shead, D. A. “Pancreatic adenocarcinoma, Version 2.2012 featured updates to the NCCN Guidelines.” Journal of the National Comprehensive Cancer Network 10.6 (2012): 703-713.
Tokars, J. I.; Bell, D.M.; Culver, D.H.; Marcus, R.; Mendelson, M.H.; Sloan, E.P.; Farber, B.F.; Fligner, D.; Chamberland, M.E.; McKibben, P.S.; and Martone, W.J. “Percutaneous Injuries During Surgical Procedures.” Journal of the American Medical Association (1992): 267 (21): 2899-2904.
Varadhachary, G. R., Tamm, E. P., Abbruzzese, J. L., Xiong, H. Q., Crane, C. H., Wang, H., … & Wolff, R. A.. “Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.” Annals of surgical oncology 13.8 (2006): 1035-1046.
Verbeke, C. S., & Menon, K. V. “Redefining resection margin status in pancreatic cancer.” HPB 11.4 (2009): 282-2
Verbeke, C. S. “Resection margins and R1 rates in pancreatic cancer–are we there yet?.” Histopathology 52.7 (2008): 787-796.
Wong, J.W.; Bai, H.; Abdul-Karim, F.W.; and MacLennan, G.T. “Simulation of Microcalcifications on Specimen Radiographs of Breast Biopsies by Inks Used in Marking the Surgical Resection Margins.”, The Breast Journal 10.5 (2004): 423-426.
Zylstra, S.; D’Orsi, C.J.; Ricci, B.A.; Halloran, E.E.; Ressequie, L.J.; Greenwald, L.; and Mondor, M.C. “Defense of Breast Cancer Malpractice Claims.” The Breast Journal7.2 (2001): 76-90.